CRMD · CorMedix Inc. · Proposed Sales
$8.08
+0.29 (+3.66%)
At close · Oct 22
Return incl. dividend (before tax)
Market Cap
$607.19M
Shares
77.94M
Volume · Oct 22
900.23K
Avg daily vol (3M)
1.12M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-01-21 | Janet Dillione | Director | 10,000 | 2026-01-21 | Merrill Lynch |
| 2025-12-30 | Alan Dunton | Director | 20,000 | 2025-12-30 | Merrill Lynch |
| 2025-12-18 | Joseph Todisco | Officer | 30,000 | 2025-12-18 | Merrill Lynch |
| 2025-12-09 | Lefkowitz Steven W | Director | 40,000 | 2025-12-09 | Fidelity Brokerage Services LLC |
| 2025-12-09 | Janet Dillione | BOD | 34,000 | 2025-12-09 | Merrill Lynch |
| 2025-11-24 | Janet Dillione | Director | 73,000 | 2025-11-24 | Merrill Lynch |
| 2025-11-14 | Dillione Janet | Director | 30,000 | 2025-11-14 | Commonwealth Financial Network |
| 2025-11-10 | Erin Mistry | Former Officer | 13,543 | 2025-11-10 | Merrill Lynch |
| 2025-11-06 | Erin Mistry | Former Officer | 13,908 | 2025-11-06 | Merrill Lynch |
| 2025-09-12 | DUNTON ALAN W | Director | 10,000 | 2025-09-12 | Merrill Lynch |
| 2025-09-12 | Todisco Joseph | Officer | 50,000 | 2025-09-12 | Merrill Lynch |
| 2025-09-09 | Hurlburt Elizabeth | Officer | 53,997 | 2025-09-09 | Merrill Lynch |
| 2025-09-09 | Zelnick Kaufman Beth | Officer | 50,000 | 2025-09-09 | Merrill Lynch |
| 2025-09-03 | David Matthew T | Former Officer | 300,000 | 2025-09-03 | Merrill Lynch |
| 2024-11-14 | Hurlburt Elizabeth | Officer | 140,027 | 2024-11-14 | Merrill Lynch |
Showing 1–15 of 15 filings
Key facts
CIK
1410098
CUSIP
21900C308
13F (30d)
14 filings
14 filers
Visit website
Investor relations